(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

July Vehicle Delivery: Li Auto, XPeng, and NIO By The Numbers

August 01st, 2023

Li Auto Inc. (Nasdaq: LI) reported a remarkable 227.5% year-over-year increase in July vehicle deliveries, reaching 34,134 units. The company surpassed the 30,000 mark for the second consecutive month, with a total of 173,251 deliveries in 2023 as of. Read more

Oshkosh and Boeing Make Waves with Multi-Million Dollar Contracts

July 31st, 2023

Oshkosh Defense LLC, a subsidiary of Oshkosh Corporation (NYSE: OSK), secured a $201,519,794 contract modification for the Family of Medium Trucks.  The Army Contracting Command, Detroit Arsenal, Michigan, is the contracting activity. $OSK. Read more

Lockheed Martin Secures $1.05B+ Defense Contracts, Northrop Grumman Inks $387M+ Defense Deal

July 31st, 2023

Lockheed Martin Corporation (NYSE: LMT) has been awarded two significant defense contracts. The first contract is a $556,114,935 modification to produce Phased Array Tracking Radar to Intercept on Target Advanced Capability-3. The second contract&nbs. Read more

Market Surges: Arista Networks and Woodward Gain Momentum On Upbeat Earnings

July 31st, 2023

Arista Networks, Inc. (NYSE: ANET) delivered strong second-quarter 2023 financial results, with earnings per share (EPS) of $1.58 and revenues of $1.459 billion, surpassing the consensus estimate of $1.44 on revenue of $1.380 billion.  The co. Read more

SEC Charges Hex Founder Richard Heart with Misappropriating Millions of Dollars of Investor Funds from Unregistered Crypto Asset Securities Offerings that Raised more than $1 Billion

July 31st, 2023

FOR IMMEDIATE RELEASE 2023-143 Washington D.C. / CRWE PRESS RELEASE / July 31, 2023 -  The Securities and Exchange Commission today charged Richard Heart (aka Richard Schueler) and three unincorporated entities that he controls, Hex, Pu. Read more

Eagle Pharma Boosts Outlook; Allarity Therapeutics Clinches Key Deal

July 31st, 2023

Shares of Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) surged in pre-market trading as the company raised its full-year 2023 adjusted non-GAAP earnings per share (EPS) guidance.  The new estimated range of $4.40 to $4.70 has been raised from th. Read more

Breaking: Archer Aviation Lands Up to $142M in Contracts; Bullish Stance On Apple

July 31st, 2023

Archer Aviation Inc. (NYSE: ACHR) has expanded its partnership with the U.S. Department of Defense (DoD) through new contracts with the U.S. Air Force valued at up to $142 million Archer will deliver up to six of its Midnight aircraft to the Air F. Read more

Earnings Preview: Etsy, Humana, McKesson, and DoorDash in Focus

July 30th, 2023

Some of the companies expected to report their financial results on Wednesday, August 02, are: Etsy, Inc. (Nasdaq: ETSY), a well-known e-commerce platform, plans to release its second quarter 2023 financial results after the market close.  . Read more

Upcoming Earnings: Pinterest, Virgin Galactic, Leidos, and Littelfuse Take the Stage

July 30th, 2023

Several companies are gearing up to report their financial results on Tuesday, August 01, shedding light on their performance and market trends, including: Pinterest, Inc. (NYSE: PINS), a prominent social media platform, will unveil its financial . Read more

Breaking: Citius Pharma Faces Regulatory Setback; Bullish View On First Solar

July 29th, 2023

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) said that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for its Biologics License Application (BLA). The application sought approval for denileukin diftitox (LYMPHIRTM), . Read more